

(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it ann...


IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics


IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer


UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter


UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges


ValiRx Loss Narrows In First Half Amid Reduction In Expenses


IN BRIEF: ValiRx Raises GBP300,700 From Broker Option


UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump